跳至主要内容
临床试验/NCT02618031
NCT02618031已完成1 期

The Capillary Index Score Trial: Phase I

Firas Al-Ali11 个研究点 分布在 1 个国家目标入组 57 人开始时间: 2016年3月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
57
试验地点
11
主要终点
Modified Rankin Score (mRS) Between Favorable CIS Group Versus Poor CIS Group.

研究概览

简要总结

This study seeks to investigate the capillary index score (CIS) to further improve patient selection of endovascular treatment (EVT) in acute ischemic stroke (AIS).

The hypothesis or idea being tested:

Patients with favorable CIS who are successfully revascularized with EVT can have successful outcomes with an extended time window for treatment.

详细描述

This study is trying to look at how the well-being of the patient following treatment is influenced by peripheral blood supply (collateral flow) to the area lacking primary blood flow due to the clot. Treatment of AIS includes EVT and medical treatment. EVT is typically not offered to patients after 6 hours of the onset of symptoms. The current study is based on the belief that patients can be successfully treated with the EVT up to 8 hours, as long as they have good peripheral blood flow (collateral flow) to the area of tissue blocked of the primary blood supply.

The study will evaluate the ability of the capillar index score (CIS) to identify patients who can be successfully treated with EVT. The CIS quantifies blood supply to the ischemic area from peripheral vessels (collateral flow) based on diagnostic cerebral angiogram. Patients are graded on a scale from 0-3, with 0 and 1 considered a poor CIS (pCIS) and 2 and 3 considered a favorable CIS (fCIS). All patients will be treated with EVT and medical treatment consistent with national guidelines.

The primary endpoint is the clinical outcome at 90 days between fCIS group versus pCIS group. The secondary endpoint is the influence of successful revascularization on outcomes for patients with fCIS or pCIS.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

The participants and investigators evaluating 90 day outcomes will be blinded to the group.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Anterior circulation acute ischemic stroke due to blockage of the intracranial internal carotid artery or middle cerebral artery (M1)
  • Within 24 hours of onset of symptoms
  • NIHSS Score is 8 or greater

排除标准

  • Contra-indication for IAT found on initial CT
  • Intracranial hemorrhage
  • Stroke mimics (tumor, herpetic encephalitis, etc.)
  • More than 1/3 hypodensity on non-enhanced head CT prior to intervention
  • ASPECT Score less than 6
  • Pre-existing disability defined as modified Rankin Scale (mRS) score more than 2
  • Pregnant women

结局指标

主要结局

Modified Rankin Score (mRS) Between Favorable CIS Group Versus Poor CIS Group.

时间窗: 90 days

The mRS Score ranges from 0-6 and describes the degree of disability or dependence after a stroke. The grades are no symptoms (0), no significant disability (1), slight disability (2), moderate disability (3), moderately severe disability (4), severe disability (5), and death (6).

次要结局

  • Complication Rate Between Favorable CIS Group Versus Poor CIS Group(1 day - 1 week)
  • Modified Rankin Score (mRS) Between Favorable CIS With Good Revascularization Versus Poor CIS With Good Revascularization.(90 days)

研究者

发起方
Firas Al-Ali
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Firas Al-Ali

Neurointerventionalist

Cleveland Clinic Akron General

研究点 (11)

Loading locations...

相似试验